RELEVANEX Trademark

Trademark Overview


On Monday, August 14, 2023, a trademark application was filed for RELEVANEX with the United States Patent and Trademark Office. The USPTO has given the RELEVANEX trademark a serial number of 98130552. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Friday, September 20, 2024. This trademark is owned by Studio 320 Inc.. The RELEVANEX trademark is filed in the Pharmaceutical Products category with the following description:

Topical analgesic creams
relevanex

General Information


Serial Number98130552
Word MarkRELEVANEX
Filing DateMonday, August 14, 2023
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateFriday, September 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 21, 2024

Trademark Statements


Goods and ServicesTopical analgesic creams

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 12, 2023
Primary Code005
First Use Anywhere DateFriday, June 14, 2024
First Use In Commerce DateFriday, June 14, 2024

Trademark Owner History


Party NameStudio 320 Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCosta Mesa, CA 92626

Party NameStudio 320 Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCosta Mesa, CA 92626

Trademark Events


Event DateEvent Description
Thursday, August 17, 2023NEW APPLICATION ENTERED
Tuesday, September 12, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 15, 2024ASSIGNED TO EXAMINER
Wednesday, April 17, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 1, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 21, 2024PUBLISHED FOR OPPOSITION
Tuesday, May 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 16, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, July 18, 2024USE AMENDMENT FILED
Thursday, July 18, 2024TEAS STATEMENT OF USE RECEIVED
Friday, September 20, 2024STATEMENT OF USE PROCESSING COMPLETE
Friday, September 20, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL

Related Keywords


relevanex creams analgesic topical